A quick peek into the report
Table of Contents
1.1 Life Sciences Research Tools Market: Overview
1.2 Middle East Life Sciences Market: Market Size
1.3 Competitive Landscape
2.1 Market Drivers
2.1.1 Growing Prevalence of Non-Communicable Diseases is Boosting the Demand for Advanced Life Science Tools
2.1.2 Increasing Government Initiatives to Boost Life Sciences Sector
2.1.3 Increased Biomedical Research amid COVID-19 Pandemic in the Middle East
2.1.4 Increasing Aceptance of Precision and Medicine in Middle East
2.1.5 Local Manufacturing will Support the Growth of Life Sciences in the Middle East
2.2 Market Restraints
2.2.1 Dearth of Skilled Professionals in the Middle East
2.2.2 Lack of Adoption of Healthcare Solutions and Equipment in Laboratories
COVID-19 Impact
4.1 By Product
4.2 By Application
4.3 By End User
4.4 Competitive Landscape
4.5 Thermo Fisher Position in the Market
5.1 By Product
5.2 By Application
5.3 By End User
5.4 Competitive Landscape
5.5 Thermo Fisher Position in the Market
6.1 By Product
6.2 By Application
6.3 By End User
6.4 Competitive Landscape
6.5 Thermo Fisher Position in the Market
7.1 By Product
7.2 By Application
7.3 By End User
7.4 Competitive Landscape
7.5 Thermo Fisher Position in the Market
8.1 By Product
8.2 By Application
8.3 By End User
8.4 Competitive Landscape
8.5 Thermo Fisher Position in the Market
9.1 By Product
9.2 By Application
9.3 By End User
9.4 Competitive Landscape
9.5 Thermo Fisher Position in the Market
Table 1: Middle East d-PCR Market
Table 2: Government Initiatives for Life Sciences in the Middle East
Table 3: Middle East Publication (By Country), December 2019-March 2021
Table 4: Middle East Publication (By Institution), December 2019-March 2021
Table 4a: Middle East Life Science Research Articles, 2016-2021 (By Country)
Table 4b: Middle East Life Science Citations, 2016-2021 (by Country)
Table 5: Product Offerings by Major Players in the Middle East PCR Market
Table 6: Product Offerings by Major Players in the Middle East PCR Market
Table 7: Product Offerings by Major Players in the Middle East RT-PCR Market
Table 8: Product Offerings by Major Players in the Middle East RT-PCR Market
Table 9 : Middle East Key Publication (By Year), 2018-March 2022
Table 10: Middle East Key Publications (By Year), 2018-March 2022
Table 11: Middle East Key Publications (By Year), 2018-March 2022
Table 12: Middle East Key Publications (By Year), 2018-March 2022
Table 13: Product Offerings by Major Players in the Middle East d-PCR Market
Table 14 : Comparison of Digital PCR Products
Table 15: Product Offerings by Major Players in the Middle East NGS Market
Table 16: Product Offerings by Major Players in the Middle East NGS Market
Table 17: Product Offerings by Major Players in the Middle East Cell Culture Market
Table 18: Product Offerings by Major Players in the Middle East Cell Culture Market
Table 19: Product Offerings by Major Players in the Middle East Western Blotting Market
Figure 1: Middle East PCR Market
Figure 2: Middle East RT-PCR Market
Figure 3: Middle East d-PCR Market
Figure 4: Middle East NGS Market
Figure 5: Middle East Cell Culture Market
Figure 6: Middle East Western Blotting Market
Figure 7: Middle East PCR Market
Figure 8: Middle East RT-PCR Market
Figure 9: Middle East NGS Market
Figure 10: Middle East Cell Culture Market
Figure 11: Middle East Western Blotting Market
Figure 12: Research Methodology
Figure 13: Primary Research Methodology
Figure 14: Market Estimation
Figure 15: Global and Middle East Life Science Research Tools Market
Figure 16: Growth Rate for Different Life Sciences Research Tools/Technologies
Figure 17: Map of Middle East countries
Figure 18: Middle East Life Sciences Market
Figure 19: Proportional Mortality Rate in Oman, KSA, U.A.E. and Qatar in 2019
Figure 20: Death due to Non-Communicable Diseases in Middle East and North Africa (MENA) in 2019
Figure 21: Trend of Personalized Medicine, 2019 and 2025
Figure 22: Percentage of People with Shortage of Skills in Middle East
Figure 23: Challenges and Barriers in LIMS Adoption in GCC
Figure 24: Middle East PCR Market, 2021-2032
Figure 25: Middle East PCR Market (by Product), $Million, 2021 vs. 2026 vs. 2032
Figure 26: Middle East PCR Market (Instruments), $Million, 2021-2032
Figure 27: Middle East PCR Market (Consumables and Software), $Million, 2021-2032
Figure 28: Middle East PCR Market (by Application), $Million, 2021 vs. 2026 vs. 2032
Figure 29: Middle East PCR Market (Clinical), $Million, 2021-2032
Figure 30: Middle East PCR Market (Research), $Million, 2021-2032
Figure 31: Middle East PCR Market (by End User), $Million, 2021 vs. 2026 vs. 2032
Figure 32: Middle East PCR Market (Biopharmaceutical and Biotechnology Companies), $Million, 2021-2032
Figure 33: Middle East PCR Market (Academic Institutes), $Million, 2021-2032
Figure 34: Middle East PCR Market (Diagnostic Companies and Laboratories), $Million, 2021-2032
Figure 35: Market Share Analysis 2020 and 2021
Figure 36: Expansion, January 2019-August 2022
Figure 37: Middle East RT-PCR Market, 2021-2032
Figure 38: Middle East RT-PCR Market (by Product), $Million, 2021 vs. 2026 vs. 2032
Figure 39: Middle East RT-PCR Market (Consumables and Software), $Million, 2021-2032
Figure 40: Middle East RT-PCR Market (Instruments), $Million, 2021-2032
Figure 41: Middle East RT-PCR Market (by Application), $Million, 2021 vs. 2026 vs. 2032
Figure 42: Middle East RT-PCR Market (Clinical), $Million, 2021-2032
Figure 43: Middle East RT-PCR Market (Research), $Million, 2021-2032
Figure 44: Middle East RT-PCR Market (by End User), $Million, 2021 vs. 2026 vs. 2032
Figure 45: Middle East RT-PCR Market (Biopharmaceutical and Biotechnology Companies), $Million, 2021-2032
Figure 46: Middle East RT-PCR Market (Academic Institutes), $Million, 2021-2032
Figure 47: Middle East RT-PCR Market (Diagnostic Companies and Laboratories), $Million, 2021-2032
Figure 48: Market Share Analysis 2020 and 2021
Figure 49: Total Key Developments during January 2019-August 2022
Figure 50: Product Launch during January 2019-August 2022
Figure 51: Total Product Launch during January 2019-August 2022 (by Company)
Figure 52: Mergers & Acquisitions, Expansions, Collaborations and Partnerships
Figure 53: Middle East Digital PCR Market, 2021-2032
Figure 54: Middle East Digital PCR Market (by Product), $Million, 2021 vs. 2026 vs. 2032
Figure 55: Middle East Digital PCR Market (Consumables and Software), $Million, 2021-2032
Figure 56: Middle East Digital PCR Market (Instruments), $Million, 2021-2032
Figure 57: Middle East Digital PCR Market (by Application), $Million, 2021 vs. 2026 vs. 2032
Figure 58: Middle East Digital PCR Market (Clinical), $Million, 2021-2032
Figure 59: Middle East Digital PCR Market (Research), $Million, 2021-2032
Figure 60: Middle East Digital PCR Market (by End User), $Million, 2021 vs. 2026 vs. 2032
Figure 61: Middle East Digital PCR Market (Biopharmaceutical and Biotechnology Companies), $Million, 2021-2032
Figure 62: Middle East Digital PCR Market (Academic Institutes), $Million, 2021-2032
Figure 63: Middle East Digital PCR Market (Diagnostic Companies and Laboratories), $Million, 2021-2032
Figure 64 : Market Share Analysis 2020 and 2021
Figure 65: Share of Key Developments and Strategies (January 2019-August 2022)
Figure 66: Share of Product Launches and Approvals by Companies (January 2019-August 2022)
Figure 67: Middle East NGS Market, 2021-2032
Figure 68: Middle East NGS Market (by Product), $Million, 2021 vs. 2026 vs. 2032
Figure 69: Middle East NGS Market (Sequencer), $Million, 2021-2032
Figure 70: Middle East NGS Market (Consumables and Software), $Million, 2021-2032
Figure 71: Middle East NGS Market (by Application), $Million, 2021 vs. 2026 vs. 2032
Figure 72: Middle East NGS Market (Clinical), $Million, 2021-2032
Figure 73: Middle East NGS Market (Research), $Million, 2021-2032
Figure 74: Middle East NGS Market (by End User), $Million, 2021 vs. 2026 vs. 2032
Figure 75: Middle East NGS Market (Biopharmaceutical and Biotechnology Companies), $Million, 2021-2032
Figure 76: Middle East NGS Market (Academic Institutes), $Million, 2021-2032
Figure 77: Middle East NGS Market (Diagnostic Companies and Laboratories), $Million, 2021-2032
Figure 78 : Market Share Analysis 2020 and 2021
Figure 79: Share of Key Developments and Strategies (January 2019-August 2022)
Figure 80: Key Developments (Product Launch, Collaboration, Partnership and Expansion), January 2019-August 2022
Figure 81: Middle East Cell Culture Market, 2021-2032
Figure 82: Middle East Cell Culture Market (by Product), $Million, 2021 vs. 2026 vs. 2032
Figure 83: Middle East Cell Culture Market (Instruments), $Million, 2021-2032
Figure 84: Middle East Cell Culture Market (Media and Reagents), $Million, 2021-2032
Figure 85: Middle East Cell Culture Market (Plastic Consumables), $Million, 2021-2032
Figure 86: Middle East Cell Culture Market (by Application), $Million, 2021 vs. 2026 vs. 2032
Figure 87: Middle East Cell Culture Market (Clinical), $Million, 2021-2032
Figure 88: Middle East Cell Culture Market (Research), $Million, 2021-2032
Figure 89: Middle East Cell Culture Market (by End User), $Million, 2021 vs. 2026 vs. 2032
Figure 90: Middle East Cell Culture Market (Biopharmaceutical and Biotechnology Companies), $Million, 2021-2032
Figure 91: Middle East Cell Culture Market (Academic Institutes), $Million, 2021-2032
Figure 92 : Market Share Analysis 2020 and 2021
Figure 93: Key Developments (Acquisition, Product Launch, Collaboration, and Expansion) January 2019- August 2022
Figure 94: Middle East Western Blotting Market, 2021-2032
Figure 95: Middle East Western Blotting Market (by Product), $Million, 2021 vs. 2026 vs. 2032
Figure 96: Middle East Western Blotting Market (Instruments), $Million, 2021-2032
Figure 96: Middle East Western Blotting Market (Instruments), $Million, 2021-2032
Figure 97: Middle East Western Blotting Market (Antibodies and Conjugates), $Million, 2021-2032
Figure 98: Middle East Western Blotting Market (Reagents and Buffer), $Million, 2021-2032
Figure 99: Middle East Western Blotting Market (Other Consumables), $Million, 2021-2032
Figure 100: Middle East Western Blotting Market (by Application), $Million, 2021 vs. 2026 vs. 2032
Figure 101: Middle East Western Blotting Market (Clinical), $Million, 2021-2032
Figure 102: Middle East Western Blotting Market (Research), $Million, 2021-2032
Figure 103: Middle East Western Blotting Market (by End User), $Million, 2021 vs. 2026 vs. 2032
Figure 104: Middle East Western Blotting Market (Biopharmaceutical and Biotechnology Companies), $Million, 2021-2032
Figure 105: Middle East Western Blotting Market (Academic Institutes), $Million, 2021-2032
Figure 106 : Market Share Analysis 2020 and 2021
Figure 107: Product Launch, January 2019-August 2022
Middle East Life Sciences Market Overview
|
Middle East PCR Market |
|||
|
Base Year |
2021 |
Market Size in 2022 |
$306.0 Million |
|
Forecast Period |
2022-2032 |
Value Projection and Estimation by 2032 |
$813.1 Million |
|
CAGR During Forecast Period |
10.27% |
|
|
|
Middle East RT-PCR Market |
|||
|
Base Year |
2021 |
Market Size in 2022 |
$163.9 Million |
|
Forecast Period |
2022-2032 |
Value Projection and Estimation by 2032 |
$596.2 Million |
|
CAGR During Forecast Period |
13.78% |
|
|
Key Questions Answered in the Report
• What is the growth potential of various life science technologies including PCR, d-PCR, RT-PCR, NGS, Cell Culture and Western Blotting in the Middle East Market?
• Who are the major players having the highest influence on the Middle East life sciences market?
• What are the major market drivers, challenges, and opportunities in the Middle East life sciences market?
• What are the underlying structures resulting in the emerging trends in the Middle East life sciences market?
• How is the COVID-19 pandemic impacting the Middle East life sciences market landscape?
• What are the potential entry barriers expected to be faced by the companies willing to enter a particular region for the development of next-generation sequencing, PCR, RT-PCR, d-PCR, cell culture and western blotting?
• What is the position of Thermo Fisher Scientific, Inc. within the entire Middle East life sciences market including PCR, d-PCR, RT-CR, NGS, cell culture and western blotting?
• Which are the key developments including product launches, M&A, Collaborations and Partnerships that have taken place within the past 3 years for all the different life sciences technologies?
• What are the underlying structures resulting in the emerging trends in the Middle East life sciences market?
• What are the expert insights for scenario and adaptation of life sciences market in various countries for PCR, d-PCR, RT-CR, NGS, cell culture and western blotting?
• How is each segment of the market expected to grow during the forecast period 2022-2032, and what is the anticipated revenue to be generated by each segment?
Introduction of Middle East Life Sciences Market
Executive Summary
The Middle East has experienced substantial advancements in the life sciences industry, driven by factors such as enhanced diagnostic capabilities, increasing prevalence of chronic and acute diseases, growth in translational research, and well-established research and development (R&D) centers. The United Arab Emirates (U.A.E.) has positioned itself as the life sciences hub of the Middle East and North Africa (MENA) region. Countries like Saudi Arabia (K.S.A.), Egypt, and Turkey have rapidly growing and highly regulated life sciences industries. These nations are leveraging precision medicine and innovative solutions to improve healthcare outcomes.
The Middle East life sciences market encompasses various technologies, including polymerase chain reaction (PCR), next-generation sequencing (NGS), digital PCR (d-PCR), cell culture, and western blotting. While RT-PCR instruments are widespread in the region, NGS instruments, such as Illumina’s Novaseq and Miseq, are commonly used in population sequencing projects. However, limited skilled professionals and slow adoption of advanced healthcare solutions in some laboratories continue to pose challenges. The post-COVID-19 era has brought increased awareness of modern molecular testing techniques, further driving the market growth.
Key Market Segments
- Middle East RT-PCR Market:
- Valued at $144.5 million in 2021, projected to reach $596.2 million by 2032 with a CAGR of 13.78%.
- Widely adopted in clinical diagnostics, especially during the COVID-19 pandemic.
- Major players include G42 Healthcare and Thermo Fisher Scientific.
- Middle East PCR Market:
- Valued at $273.6 million in 2021, expected to grow to $813.1 million by 2032 at a CAGR of 10.27%.
- Conventional and RT-PCR technologies dominate this segment, supported by initiatives such as the G42-BGI collaboration for COVID-19 detection.
- Middle East d-PCR Market:
- Estimated at $15.6 million in 2021, projected to reach $73.7 million by 2032 at a CAGR of 15.19%.
- Emerging market with limited adoption in laboratories. Bio-Rad Laboratories and QIAGEN are key contributors.
- Middle East NGS Market:
- Valued at $215.6 million in 2021, expected to grow to $1,285.8 million by 2032 with a CAGR of 15.71%.
- Dominated by Illumina and Thermo Fisher Scientific, supported by regional genome projects such as the Emirati Genome Project and Qatar Genome Project.
- Middle East Cell Culture Market:
- Valued at $237.5 million in 2021, forecasted to reach $561.9 million by 2032 with a CAGR of 7.74%.
- Major players include GE Healthcare and Thermo Fisher Scientific, with applications in biopharma and academic research.
- Middle East Western Blotting Market:
- Valued at $44.9 million in 2021, projected to grow to $93.2 million by 2032 at a CAGR of 6.57%.
- Key players include Bio-Rad Laboratories and Cleaver Scientific.
- Increased Research Activities:
- Government investments in genomic and proteomic research are boosting the adoption of advanced technologies like NGS and d-PCR.
- Impact of COVID-19:
- Accelerated the adoption of RT-PCR and d-PCR technologies for viral detection and genomic surveillance.
- Growing Biopharma Sector:
- Increasing R&D activities in biopharmaceuticals are driving demand for cell culture and western blotting techniques.
- Public-Private Collaborations:
- Initiatives such as the Emirati Genome Project and Saudi Genome Project demonstrate the role of partnerships in advancing the life sciences sector.
- Digital Transformation:
- Over 57% of researchers in the region are engaged in digital innovation projects to mitigate compliance risks and improve operational efficiency.
Market Restraints
- Lack of Skilled Professionals:
- Limited availability of trained personnel to operate advanced molecular testing equipment.
- Slow Adoption of Technology:
- Delays in procurement and setup of advanced equipment due to regional logistics and supply chain challenges.
- High Cost of Equipment:
- Expensive instruments like NGS sequencers and d-PCR machines restrict accessibility to smaller labs.
- Key Players: Illumina, Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN, and GE Healthcare dominate the Middle East life sciences market.
- Strategic Developments: From 2019 to 2022, the market witnessed 19 acquisitions, 19 product launches, 7 business expansions, and 4 funding initiatives.
- Notable Collaborations: G42 Healthcare’s partnerships with Seegene, InterSystems, and BGI Group enhanced molecular diagnostic capabilities.
- United Arab Emirates (U.A.E.):
- Positioned as the life sciences capital of the Middle East.
- Hosts prominent genome projects like the Emirati Genome Project.
- Saudi Arabia:
- Focused on reducing genetic diseases through initiatives like the Saudi Genome Project.
- Prominent contributor to the biopharma and biotechnology sectors.
- Qatar:
- Home to the Qatar Genome Project, advancing population genomics.
- Egypt and Turkey:
- Emerging hubs for life sciences research, supported by growing government investments.
- Population Genomics:
- Large-scale projects like the U.A.E. Genome Project aim to map genetic diversity and improve healthcare outcomes.
- Adoption of Digital Solutions:
- Increasing use of laboratory information management systems (LIMS) and other digital tools for research and diagnostics.
- Expansion of Biopharma:
- Growth in cell culture applications and proteomics research to meet rising demand for biologics.
- Innovation in Diagnostic Technologies:
- Development of high-throughput, cost-effective diagnostic tools for widespread use in clinical setting
The Middle East life sciences market is poised for significant growth, driven by advancements in genomics, proteomics, and cell biology. With a focus on precision medicine and digital transformation, the region is set to overcome challenges related to skilled labor shortages and logistical delays. Strategic investments in public-private partnerships and infrastructure development will further solidify the Middle East’s position as a global hub for life sciences innovation.
Middle East Life Sciences Market
Focus on Polymerase Chain Reaction (PCR), Digital PCR (d-PCR), Real-Time PCR (RT-PCR), Next-Generation Sequencing (NGS), Cell Culture, and Western Blotting - Analysis and Forecast, 2022-2032